Literature DB >> 12407288

[A patient with pulmonary endometriosis].

J P L'huillier1, J Salat-Baroux.   

Abstract

A 30-year-old woman consulted for recent repeated episodes of hemoptysis occurring at the onset of the menses a few months after interruption of estrogen-progesterone treatment. This patient's only surgical history involved uterine curetage. She was a smoker and had cumulated 10 pack-years. Physical examination and chest x-rays were normal. Bronchial endoscopy and cytological examination of the bronchial aspiration were normal. Thoracic CT demonstrated an alveolar image in the right lower lobe. A second CT performed later after resolution of the episode of hemoptysis was normal. Laparoscopy was performed and visualized an endometrial nodule in the pelvis which was removed. The patient's clinical signs disappeared after treatment with triptoreline. Bronchopulmonary endometriosis is an uncommon condition. The main manifestations are catamenial hemoptysis during the first days of the menses. Chest pain is exceptional. Diagnosis may result from an incidental discovery. A traumatic intervention on the uterus is often found in the patient's history. The most commonly proposed pathogenic mechanism involves hematogenic migration following a uterine procedure. Imaging does not disclose specific signs and bronchial endoscopy is often normal but may demonstrate a tracheal or bronchial plaque of endometriosis, or exceptionally endometrial tissue in the endoscopy biopsies. LH-RH agonists remain the current treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407288

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  2 in total

Review 1.  Synchronous rectovaginal, urinary bladder, and pulmonary endometriosis.

Authors:  Georgios E Hilaris; Christopher K Payne; Joelle Osias; Walter Cannon; Camran R Nezhat
Journal:  JSLS       Date:  2005 Jan-Mar       Impact factor: 2.172

Review 2.  Lung Diseases Unique to Women.

Authors:  Rachel N Criner; Abdullah Al-Abcha; Allison A Lambert; MeiLan K Han
Journal:  Clin Chest Med       Date:  2021-09       Impact factor: 4.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.